Download - Overview of Dendritic Cell Development Poster

Transcript
Page 1: Overview of Dendritic Cell Development Poster

Human Mouse

IFN-I, IFN-III (IFN-λ)CXCL-10 (IP-10)

TNF

IL-1β, IL-6, IL-8 IL-10, IL-12

IL-23TNF

Lineage–, CD45+, MHCII (HLA-DR)+, CD11c+

CD16CD64CD1a, CD1c CD11b, CD14+/–

CD172a (Sirp-α) CD206, CD209 (DC-SIGN)CD367 (DCIR/CLEC4A)CD369 (Dectin-1/CLEC7A)CD371 (CLEC12A)CLEC6ATLR3lo, TLR4, TLR7, TLR8CD207 (Langerin)–

Lineage–, CD45+,MHCII (HLA-DR)+, CD11c+

CD1a, CD64CD11bCD1cCD172a (Sirp-α)CD367 (DCIR/CLEC4A)CD369 (Dectin-1/CLEC7A)CLEC6ATLR1–3, TLR6, TLR7, TLR10CD14–

CD207 (Langerin)–

CD209 (DC-SIGN)–

CD324 (E-Cadherin)–

CD326 (EpCAM)–

Lineage–, CD45+,MHCII (HLA-DR)+, CD11c+

CD14CD209 (DC-SIGN)CD11bCD1cCD172a (Sirp-α)+ CD367 (DCIR/CLEC4A)CD369 (Dectin-1/CLEC7A)TLR1–3, TLR6, TLR7CD1a–

CD207 (Langerin)–

CD324 (E-Cadherin)–

CD326 (EpCAM)–

IL-1β, IL-6, IL-10,IL-12, IL-23, TNF

CD14

CD117 (c-kit)

CD135/FLT3CD117 (c-kit)

IRF7, IRF8,SpiB

Lineage–, CD45+,MHCII (HLA-DR)+, CD11c+

CD207 (Langerin)CD324 (E-Cadherin)CD326 (EpCAM)CD11blo

CD1ahi, CD1cCD172a (Sirp-α)CD369 (Dectin-1/CLEC7A)CD371 (CLEC12A)CLEC6A TLR1, TLR2, TLR3lo, TLR6CD14–

Lineage–, CD45+,MHCII (HLA-DR)+, CD11clo/–

CD123hi

CD303CD304 CD85g (ILT7)CD4CD45RACD272 (BTLA)CD367 (DCIR/CLEC4A)CD371 (CLEC12A)±

TLR7hi, TLR9hi

CD11b–

CD14–

IFN-I, IFN-III (IFN-λ)IL-6, IL-8

IP-10 (CXCL10)TNF

Lineage–, CD45+, MHCII (HLA-DR)+, CD11c+/lo

CD141hi

CD370 (CLEC9A)NECL2 CD11blo

CD205 (DEC-205)hi

CD272 (BTLA)hi

CD366 (TIM-3)CD367 (DCIR/CLEC4A)CD369 (Dectin-1/CLEC7A)CD371 (CLEC12A)TLR3, TLR8XCR1CD1a–, CD14–

Lineage–, CD45+,MHCII (HLA-DR)+, CD11c+

CD1cCD172a (Sirp-α)CLEC6ACD11b+/lo

CX3CR1CD272(BTLA)CD366 (TIM-3)CD367 (DCIR/CLEC4A)CD369 (CLEC7A)CD371 (CLEC12A)TLR3lo, TLR4lo, TLR8, TLR10lo

CD1a–, CD14lo/–

CSFFLT3L

M-CSF

IL-3

CommonMyeloid

ProgenitorCells

Monocyte

CD1a+

DermalDCs

CD14+

DermalDCs

InflammatoryMonocyte-

derivedDCs

LangerhansCells

PlasmacytoidDCs

IRF8, BATF3

CD141+

ConventionalMyeloid DCsIRF4

CD1c+

ConventionalMyeloid DCs

CommonDendriticPrecursor

Cells

IFN-I, IFN-III (IFN-λ)IL-12

CXCL-10 (IP-10)TNF

IL-1β, IL-6, IL-8IL-10, IL-12

IL-23TNF

IL-1β, IL-6, IL-8IL-10, IL-12

IL-23TNF

Lineage–, CD45+,MHCII+, CD11c+

CD64 CD11bCD209a (DC-SIGN) CD272 (BTLA)lo

Ly-6CTLR1-6, TLR7-8, TLR10CD8a–, CD14–

Lineage–, CD45+,MHCII+, CD11c+

CD207 (Langerin)CD11blo

CD172a (Sirp-α)–

Lineage–, CD45+,MHCII+, CD11c+

CD11b±

CD172a (Sirp-α)CD207 (Langerin)–

Lineage–, CD45+,MHCII+, CD11c+

CD11bCD172a (Sirp-α)CD209a (DC-SIGN)±

CD272 (BTLA)lo

F4/80TLR5, TLR7, TLR9CX3CR1CD4–, CD8a–

CD14–

XCR1–

IL-1β, IL-6 IL-10,IL-12, IL-23, TNF

CD11b, CD115Ly6C

CD117 (c-kit)

CD117 (c-kit)CD135/FLT3

IRF7, IRF8, BATF3hiSpiB, Zbtb46–

Lineage–, CD45+,MHCII+, CD11c+

CD207 (Langerin)CD324 (E-Cadherin)CD326 (EpCAM)CD11bCD24CD172a (Sirp-α)CD205 (DEC-205)F4/80TLR3, TLR11CD8–, CD14–

CD370 (Clec9a)–

Lineage–, CD45+,MHCII+, CD11clo

CD45R (B220)CD317 (BST-2)Ly6CSiglec-HCD4CD172a (Sirp-α)CD209a (DC-SIGN)CD272 (BTLA) CD370 (Clec9a)TLR7hi, TLR9hi

CD11b–

CD14–

Lineage–, CD45+,MHCII+, CD11chi

CD103CD205 (DEC-205)CD207 (Langerin)CD272 (BTLA)hi

CD370 (Clec9a)NECL2TLR3, TLR4, TLR11XCR1CD4–, CD8a–

CD11b–, CD14–

F4/80–

CX3CR1–

IFN-I, IFN-III (IFN-λ)IL-6, IL-8

IP-10 (CXCL10)TNF

IFN-I, IFN-III (IFN-λ)IL-12

CXCL-10 (IP-10)TNF

IL-15

Lineage–, CD45+,MHCII+, CD11chi

CD8aCD205 (DEC-205)CD207 (Langerin)+/–

CD272 (BTLA)hi

CD370 (Clec9a) NECL2TLR3, TLR4, TLR11XCR1CD4–

CD11b–

CD14–

Lineage–, CD45+,MHCII+, CD11chi

CD4CD11bCD172a (Sirp-α)CD205 (DEC-205)CD272 (BTLA)lo

ESAMF4/80TLR5, TLR7, TLR9 CX3CR1CD8a–

CD14–

CSFFLT3L

TGFb1M-CSF

FLT3LIFN Type I

FLT3L

CommonMyeloid

ProgenitorCells

Monocyte

CD207+

DermalDCs

CD207–Dermal

DCs

InflammatoryMonocyte-

derivedDCs

LangerhansCells

PlasmacytoidDCs

IRF8, BATF3,Zbtb46

CD8a+

ConventionalLymphoid

Resident DCsIRF4, Zbtb46

BATF3hi

CD4+Conventional

LymphoidResident DCs

IRF4, IRF2Zbtb46, BATF3hi

CD11b+

ConventionalMigratory

DCs

CommonDendriticPrecursor

Cells

Pre-Conventional

DendriticCell

IRF8, BATF3,Zbtb46

CD103+

ConventionalMigratory

DCs

Zbtb46–

IL-15

bdbiosciences.com© 2016 BD. BD and the BD Logo are trademarks of Becton, Dickinson and Company.

BD Life Sciences, San Jose, CA, 95131, USA

For Research Use Only. Not for use in diagnostic or therapeutic procedures.23-19088-00

Overview of Dendritic Cell Development

Core dendritic cell phenotyping markers Lineage (Hu): CD3–, CD19–, CD20–, CD56–, CD141

Lineage (Ms): CD3–, CD19–, CD49b– or NK1.1–, CD14–

Dendritic cell subset markers (positive) TLR7, TLR8 and TLR9 are endosomal and require

intracellular staining

Dendritic cell subset markers (negative)

Secreted cytokinesTranscription factorsMarkers on this schematic can be altered as a result of cellular environment, differentiation state and other factors. DC biomarker profiles were obtained from RNA and protein level analysis provided in peer reviewed publications and public databases. Visit bdbiosciences.com/DC for more information.

KEY

1 CD14 is negative or low in all Human DC subsets except for CD14+ Dermal DCs and inflammatory DCs.